Is obesity an inflammatory condition?

Nutrition

Volumn 17, Issue 11-12, 2001, Pages 953-966

  Das, U N ^a  

^a EFA Sciences LLC   (United States)

Author keywords

Cytokines; Inflammation; Long chain polyunsaturated fatty acids; Obesity

Indexed keywords

ACETYLCHOLINE; BONE MORPHOGENETIC PROTEIN; C REACTIVE PROTEIN; CYTOKINE; DOPAMINE; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 6; LEPTIN; MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE Y; NEUROTRANSMITTER; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; POLYUNSATURATED FATTY ACID; SEROTONIN; STATIN; TUMOR NECROSIS FACTOR ALPHA;

ARTIFICIAL MILK; BLOOD LEVEL; BRAIN; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN LEVEL; BREAST FEEDING; BREAST MILK; CARDIOVASCULAR RISK; CYTOKINE PRODUCTION; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; EXERCISE; FOOD INTAKE; HEART DISEASE; HUMAN; INFLAMMATION; NEGATIVE FEEDBACK; NERVOUS SYSTEM DEVELOPMENT; OBESITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; RISK FACTOR;

EID: 0035666553     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(01)00672-4     Document Type: Article

References (230)

1. The spread of the childhood obesity epidemic
2. Annual deaths attributable to obesity in the United States
3. Onset of obesity in a 36 year birth cohort study
4. Childhood weight affects adult morbidity and mortality
5. Secular trends in the body mass index of Canadian children
6. Childhood weight and growth rate as predictors of adult mortality
7. Body mass index and mortality in a prospective cohort of US adults
8. Decreasing sedentary behaviours in treating pediatric obesity
9. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984 to 1992
10. C reactive protein and its relation to cardiovascular risk factors: A population based cross-sectional study
11. Elevated C-reactive protein levels in overweight and obese adults
12. Low-grade systemic inflammation in overweight children
13. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study
14. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
15. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
16. Plasma concentrations of C-reactive protein and risk of developing peipheral vascular disease
17. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction
18. Function of C-reactive protein
19. C-reactive protein concentration in children: Relationship to adiposity and other cardiovascular risk factors
20. Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells
21. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-3, in vivo
22. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid
23. The acute phase response in patients receiving subcutaneous IL-6
24. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects
25. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice
26. C-reactive protein: A physiological activator of interleukin-6 receptor shedding
27. Serum soluble IL-6 receptor concentrations correlate with stages of multiple myeloma defined by serum beta2-microglobulin and C-reactive protein
28. Soluble interleukin-6 receptors in inflammatory bowel disease: Relation to circulating IL-6
29. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha
30. Concentrations and origins of soluble interleukin-6 receptor-α in serum and synovial fluid
31. C-reactive protein: Structural biology, gene expression and host defense function
32. Human C-reactive protein inhibits neutrophil chemotaxis in vitro: Possible implications for adult respiratory distress syndrome
33. Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein
34. Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis
35. 1c levels in healthy women
36. Serum concentrations of TNF-α and soluble TNF-α receptors in obesity
37. Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men
38. Can free radicals cause acute myocardial infarction?
39. Atherosclerosis-an inflammatory disease
40. Ageing, tumor necrosis factor-alpha (TNF-alpha) and atherosclerosis
41. The role of TNF-alpha and TNF receptors in obesity and insulin resistance
42. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease
43. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects
44. Relationship between insulin resistance and abnormal lipid profile in obese adolescents
45. Obesity and body fat distribution in relation to the incidence of non-insulin dependent diabetes mellitus: A prospective cohort study of men in the Normative Aging Study
46. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
47. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
48. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
49. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly
50. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
51. Plasma cytokine parameters and mortality in patients with chronic heart failure
52. GLUT-4, tumor necrosis factor, essential fatty acids and daf-genes and their role in glucose homeostasis, insulin resistance, non-insulin dependent diabetes mellitus and longevity
53. Stimulation of free radical generation in human leukocytes by various agents including tumor necrosis factor is a calmodulin dependent process
54. Oxy radicals and their clinical implications
55. Ageing, tumor necrosis factor-alpha (TNF-alpha) and atherosclerosis
56. Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1
57. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease
58. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease
59. Oxidant stress, anti-oxidants and nitric oxide in non-insulin dependent diabetes mellitus
60. Are free radicals involved in the pathobiology of human essential hypertension?
61. Lipid lowering improves endothelial functions
62. Central nervous system control of food intake
63. Effects of phentermine on striatal dopamine and serotonin release in conscious rats: In vivo microdialysis study
64. Mesolimbic dopaminergic system activity as a function of food reward: A microdialysis study
65. Body weight gain induced by antipsychotic drugs: Mechanisms and management
66. Behavioural microanalysis of the role of dopamine in amphetamine anorexia
67. The effects of cocaine on food intake of baboons before, during and after a period of repeated desipramine
68. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotrophin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice
69. 2 dopamine receptor gene with receptor-binding characteristics in alcoholism
70. D2 dopamine receptor gene and obesity
71. Genetic variants of the human obesity (OB) gene: Association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRDR) gene
72. Brain dopamine and obesity
73. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive silence?
74. Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments
75. Reward deficiency syndrome
76. Striatal dopamine turnover during treadmill running in the rat: Relation to the speed of running
77. Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolites in presenescent older rats
78. Cerebrospinal fluid and plasma leptin measurements: Covariability with dopamine and cortisol in fasting humans
79. Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings
80. Dopamine is required for hyperphagia in Lep(ob/ob) mice
81. Dopamine and serotonin VMN release is related to feeding state in obese and lean Zucker rats
82. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability
83. Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: Further evidence for a role of nitric oxide in feeding
84. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y
85. Acetylcholine stimulates the release of nitric oxide from rat spinal cord
86. 5-Hydroxytryptamine evokes endothelial nitric oxide synthase activation in bovine aortic endothelial cell cultures
87. Involvement of nitric oxide in the 5-HT1A autoreceptor-mediated hyperphagia in rats
88. A nitric oxide synthase inhibitor reduces hyperphagia induced in rats by the 5-HT(1A) receptor agonist, 8-OH-DPAT, independently of hypothalamic serotonin metabolism
89. Nitric oxide transforms serotonin into an inactive form and this affects neuromodulation
90. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo
91. Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis
92. Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase
93. The nitric oxide system in a chronic deficiency of mesostriatal dopamine: The action of nitroglycerin
94. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts
95. Striatal neuropeptide Y beurones are under the influence of the nigrostriatal dopaminergic pathway: Immunohistochemical evidence
96. D1 and D2 dopamine receptor mediation of amphetamine induced acetylcholine release in nucleus accumbens
97. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo
98. Serotonergic regulation of acetylcholine release in rat frontal cortex
99. Involvement of cholinergic neurons in the release of dopamine elicited by stimulation of mu-opioid receptors in striatum
100. Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia
101. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters
102. IL-1 beta mediates leptin induction during inflammation
103. Leptin regulates proinflammatory immune responses
104. Leptin actions on food intake and body temperature are mediated by IL-1
105. IL-1beta and IL-6 excite neurons and suppress cholinergic neurotansmission in the myenteric plexus of the guinea pig
106. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
107. Dopamine attenuates the chemoattractant effect of interleukin-8: A novel role in the systemic inflammatory response syndrome
108. Effects of endotoxin and tumor necrosis factor alpha on regional brain neurotransmitters in mice
109. The VMH-dietary obese rat: A new model of non-insulin dependent diabetes mellitus
110. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats
111. Evidence of a physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia
112. Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats
113. Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozotocin-induced diabetic rats
114. Aspects of hypothalamic neuronal systems in VMH lesion-induced obese rats
115. Long-term infusion of norepinephrine plus serotonin into the ventromedial hypothalamus impairs pancreatic islet function
116. Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats
117. The biphasic changes in splenic natural killer cell activity following ventromedial hypothalamic lesions in rats
118. Neuroimmunomodulatory actions of hypothalamic interferon-alpha
119. Effects of chronic stress on hypothalamic interleukin-1beta, interleukin-2, and gonadotrophin-releasing hormone gene expression in ovariectomized rats
120. Interleukin-1 alpha injection into ventromedial hypothalamic nucleus of normal rats depresses food intake and increases release of dopamine and serotonin
121. Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat
122. Interleukin-1 beta-induced anorexia and pyrexia in rat: Relationship to hypothalamic neuropeptide Y
123. Ventromedial hypothalamic lesions impair glucoregulation in response to endotoxin
124. Differential effects of tumor necrosis factor-alpha and -beta on rat ventromedial hypothalamic neurons in vitro
125. Autoradiographic localization of insulin receptors in rat brain: Prominence in olfactory and limbic areas
126. The brain-lipid-heart connection
127. Role of brain insulin receptor in control of body weight and reproduction
128. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: A putative hypothalamic site for energy homeostasis
129. Insulin-like growth factor 1 stimulates the release of acetylcholine from rat cortical slices
130. A new concept in neurodegenration: TNF alpha is a silencer of survival signals
131. A new mechanism of neurodegeneration: Proinflammatory cytokine inhibits receptor signaling by a survival peptide
132. Role of brain insulin receptor in control of body weight and reproduction
133. A receptors to postsynaptic domains by insulin
134. Leptin modulates the T-cell immune response and reverses starvation-induced imunosuppression
135. Is insulin an anti-inflammatory molecule?
136. Possible beneficial action(s) of glucose-insulin-potassium regimen in acute myocardial infarction and inflammatory conditions: A hypothesis
137. Fetal origins of adult disease - The hypothesis revisited
138. Food, growth and time
139. Effect of litter size on plasma cholesterol and insulin and some liver and adipose tissue enzymes in adult rodents
140. Programming of cholesterol metabolism by breast or formula feeding
141. Nutritional growth restriction and the nervous system
142. Development and recovery
143. Relation of infant diet to childhood health: Seven year follow up of cohort of children in Dundee infant feeding study
144. Randomised trial of early diet in preterm babies and later intelligent quotient
145. Early nutrition in preterm infants and later blood pressure: Two cohorts after randomized trials
146. Do breast-feeding and delayed introduction of solid foods protect against subsequent obesity?
147. Feeding practices in infancy and prevalence of obesity in preschool children
148. Duration of breast feeding associated with obesity during adolescence
149. Does breast-feeding protect against childhood obesity?
150. Early infant feeding and growth status of US-born infants and children aged 4-71 mo: Analysis from the third National Health and Nutrition Examination Survey, 1988-1994
151. Infant feeding and adult glucose tolerance, lipid profile, blood pressure, and obesity
152. Breast feeding and obesity: Cross sectional study
153. Breast vs bottle: Endocrine responses are different with formula feeding
154. Metabolic and endocrine responses to a milk feed in six-day-old term infants: Differences between breast and cow's milk formula feeding
155. Effects of epidermal growth factor (EGF), platelet derived growth factor (PDGF) and fibroblast growth factor (FGF) on human adipocyte development and function
156. Transforming growth factor beta (TGF-beta) inhibits the differentiation of human adipocyte precursor cells in primary culture
157. Changing composition of human milk and early development of an appetite control
158. Nutritional influences in the evolution of mammalian brain
159. Tissue levels of polyunsaturated fatty acids during early human development
160. DHA status of preterm infants at birth and following feeding with human milk or formula
161. Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex
162. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants
163. Modulation of learning, pain thresholds, and thermoregulation in the rat by preparations of free purified α-linolenic and linoleic acids: Determination of the optimal w3-to-w6 ratio
164. Arachidonic acid status correlates with first year growth in preterm infants
165. Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes
166. Hippocampal acetylcholine release during memory testing in rats: Augmentation by glucose
167. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats
168. Muscarinic acetylcholine receptors induce the expression of the immediate early growth regulatory gene Cyr61
169. Dopamine D-5 receptor modulates hippocampal acetylcholine release
170. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses
171. Nutrients, essential fatty acids and prostaglandins interact to augment immune responses and prevent genetic damage and cancer
172. Essential fatty acids: Biology and their clinical implications
173. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: A specific vascular action of insulin
174. Newer uses of glucose-insulin-potassium regimen
175. Can glucose-insulin-potassium regimen suppress inflammatory bowel disease?
176. Polyunsaturated fatty acids are potent neuroprotectors
177. Effect of n-6 and n-3 fatty acids on the proliferation and secretion of TNF and IL-2 by human lymphocytes in vitro
178. Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins
179. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells
180. Beneficial effect of eicosapentaenoic and docosahexaenoic acids in the management of systemic lupus erythematosus and its relationship to the cytokine network
181. Inhaled nitric oxide prevents IL-1 induced neutrophil accumulation and associated acute edema in isolated rat lungs
182. Insulin resistance and hyperinsulinemia: Are they secondary to an alteration in the metabolism of essential fatty acids?
183. GLUT-4, tumor necrosis factor, essential fatty acids and daf-genes and their role in insulin resistance and non-insulin dependent diabetes mellitus
184. Bone morphogenetic protein-6 production in human osteoblastic cell lines
185. Opposing effects of bone morphogenetic proteins on neuron production and survival in the olfactory receptor neuron lineage
186. BMP signaling is essential for development of skeletogenic and neurogenic cranial neural crest
187. Bone morphogenetic proteins are required in vivo for the generation of sympathetic neurons
188. Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9
189. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress
190. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite
191. Noggin is a negative regulator of neuronal differentiation in developing neocortex
192. Regulation of the onset of neural crest migration by coordinated activity of BMP4 and noggin in the dorsal neural tube
193. Role of nitric oxide in the inhibition of BMP-2 mediated stimulation of proteoglycan synthesis in articular cartilage
194. Prostaglandin E1 and recombinant bone morphogenetic protein effect on strength of hydroxyapatite implants
195. Promotion of the osteogenetic activity of recombinant human bone morphogenetic protein by prostaglandin E1
196. Protein prenylation: Molecular mechanisms and functional consequences
197. Essential fatty acids and osteoporosis
198. HMG-CoA reductase activity in the liver of rats with hereditary hypertriglyceridemia: Effect of dietary fish oil
199. Regulation of mevalonate synthesis in rat mammary glands by dietary n-3 and n-6 polyunsaturated fatty acids
200. Essential fatty acids as possible mediators of the actions of statins
201. Late effects of breast-feeding and early weaning: Seven-year prospective study in children
202. Role of prolonged feeding in infant growth
203. The fatty acid composition of skeletal muscle membrane phospholipid: Its relationship with the type of feeding and plasma glucose levels in young children
204. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease
205. n-3 essential fatty acids decrease weight gain in genetically obese mice
206. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation
207. Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men
208. Effect of highly purified eicosapentaenoic acid ethyl ester on insulin resistance and hypertension in Dahl salt-sensitive rats
209. Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: But, why and how?
210. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain
211. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice
212. Fatty acids and hypolopidemic drugs regulate peroxisome proliferator-activated receptors α- and γ-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus
213. Essential fatty acids, lipid peroxidation and apoptosis
214. The role of breastfeeding in obesity
215. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of ischemic heart disease
216. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation
217. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss
218. Effects of pregnancy and exercise on concentrations of the metabolic markers tumor necrosis factor alpha and leptin
219. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals
220. Inhibition of proinflammatory cytokine production by pravastatin
221. Statins and monocytes
222. Effect of statins on C-reactive protein in patients with coronary artery disease
223. Statins as a newly recognized type of immunomodulator
224. Pravastatin and the development of diabetes mellitus
225. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
226. The hormone resistin links obesity to diabetes
227. A role for ghrelin in the central regulation of feeding
228. Ghrelin induces adiposity in rodents